Clarithromycin Subject 4003/3212/003 with ERSP Isolates, PPb

1/14/03


Click here to start


Table of Contents

Clarithromycin Subject 4003/3212/003 with ERSP Isolates, PPb

All CAP Studies (Pooled): Key Demographics, mITT

Post-Marketing Reports of Symptomatic Liver Injury : 200214202DE (1)

Post-Marketing Reports of Symptomatic Liver Injury : 200214202DE (2)

Post-Marketing Reports of Symptomatic Liver Injury : 200213635DE

Post-Marketing Reports of Symptomatic Liver Injury : 200211855DE

Post-Marketing Reports of Symptomatic Liver Injury : 200211440DE

Telithromycin: Anaerobes MIC Ranges (g/mL)

Subject 3014/2004/002 02-HS-598-Live-4x-2

Subject 3014/2004/002 02-HS-598-Live-4x-T

Subject 3014/2004/002 02-HS-598-Live-40x-4

Subject 3014/2004/002 02-HS-598-Live-40x-2

Subject 3014/2004/002 02-HS-598-Live-10x-2

Subject 3000/502/1069 2758470-99-4879-4x001

Subject 3000/502/1069 2758470-99-4879-10x001

Subject 3000/502/1069 2758470-99-4879-20x002

Subject 3000/502/1069 2758470-99-4879-40x001

Subject 3000/502/1069 2758470-99-4879-40x003

Subject 3000/502/1069 2758470-liver-4x-T001

Subject 3000/502/1069 2758470-liver-20x001

Subject 3000/502/1069 2758470-liver-40x001

Telithromycin Subject 3000/605/1091

?QTc vs Telithromycin Plasma Concentration in Phase III Studies

Study 3014: Usual Care

Study 3014: Cardiac AESIs in Subjects at Risk of TdP (1)

Study 3014: Cardiac AESIs in Subjects at Risk of TdP (2)

Subject 200214256DE: Spontaneous Report: Fatal Ventricular Arrhythmia (1)

Subject 200214256DE: Spontaneous Report: Fatal Ventricular Arrhythmia (2)

Subject 200214256DE: Spontaneous Report: Fatal Ventricular Arrhythmia (3)

Subject 200214256DE: Spontaneous Report: Fatal Ventricular Arrhythmia (4)

Subject 200214256DE: Spontaneous Report: Fatal Ventricular Arrhythmia (5)

Author: Michael Worsham